Rhabdomyolysis, acute renal failure and hepatopathy induced by lovastatin monotherapy

Japanese Heart Journal

Volumn 38, Issue 4, 1997, Pages 541-545

  Chu, Po Hsien ^a   Chen, Wei Jan ^a   Chiang, Cheng Wen ^a   Lee, Ying Shiung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acute renal failure; Lovastatin; Rhabdomyolysis

Indexed keywords

CYCLOSPORIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIVER TOXICITY; ORGAN TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; RHABDOMYOLYSIS;

EID: 0030855706     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.38.541     Document Type: Article

References (21)

1. Corpier CL, Jones PH, Suki WN, et al. Rhabdomyolysis and renal injury with lovastatin use: report of two cases in cardiac transplant recipients. JAMA 1988; 260: 239-41.
2. Norman DJ, Illingworth DR, Munson J, Hosenpud J. Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin (letter). N Engl J Med 1988; 318: 46-7.
3. East C, Alivizatos PA, Grundy SM, Jones PH, Farmer JA. Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation (letter). N Engl J Med 1988; 318: 47-8.
4. Reaven P, Witztum JL. Lovastatin, nicotinic acid and rhabdomyolysis (letter). Ann Intern Med 1988; 109: 597-8.
5. Ayanina JZ, Fuchx CX, Stones RM. Lovastatin and rhabdomyolysis (letter). Ann Intern Med 1988; 109: 682-3.
6. Goldman JA, Fishman AB, Lee JE, Johnson RJ. The role of cholesterol-lowing agents in drug-induced rhabdomyolysis and polymyositis (letter). Arthritis Rheum 1989; 32: 358-9.
7. Kogan AD, and Orenstein S. Lovastatin-induced acute rhabdomyolysis. Postgrad Med J 1990; 66: 294-6.
8. Manoukian AA, Bhagava NV, Hayashi T, Nestor TA, Rios C, Scottolini AG. Rhabdomyolysis secondary to lovastatin therapy. Clin Chem 1990; 36: 2145-7.
9. Marais GE, Larson KK. Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. Ann Intern Med 1990; 112: 228-30.
10. Pierce LR, Wysowski DK, Gross TP. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 1990; 267: 71-5.
11. Sylvain-Moore H, Worden JPJ. Lovastatin-associated rhabdomyolysis. Heart Lung 1991; 20: 464-6.
12. Spach DH, Bauwens JE, Clark CD, Burke WG. Rhabdomyolysis associated with lovastatin and erythromycin use. West J Med 1991; 154: 213-5.
13. Chrysanthopoulos C, Kounis N. Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine. BMJ 1992; 304: 1225.
14. Zatarain GF, Navarro V, Garcia H, Villatoro J, Calvo C. Rhabdomyolysis and acute renal failure associated with lovastatin (letter). Nephron 1994; 66: 483-4.
15. Alejandro DS, Petersen J. Myoglobinuric acute renal failure in a cardiac transplant patient taking lovastatin and cyclosporine. J Am Soc Neph 1994; 5: 153-60.
16. Marinella MA. More on lovastatin. West J Med 1995; 162: 176-7.
17. Lovastatin Study Group II. Therapeutic response to lovastatin (mevenolin) in nonfamilial hypercholesterolemia. JAMA 1986; 256: 2829-34.
18. Tobert JA. Efficacy and long-term adverse effect pattern of lovastatin. Am J Cardiol 1988; 62: 28J-34J.
19. The Lovastatin Study Group III. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia: a multicenter study. JAMA 1988; 260: 359-66.
20. Bradford RH, Shear CL, Chremos AN, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results. 1. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch Intern Med 1991; 151: 43-9.
21. Wallace CS, Mueller BA. Lovastatin-induced rhabdomyolysis in the absence of concomitant drugs. Ann Pharmacol 1992; 26: 190-2.